Parliament Workbench
Data: Motions & questions to 19 Nov 2026 · Votes to 12 Nov 2026

Members' Business Motion · S5M-09067 · Session 5

Cystic Fibrosis and Medicines Access

Lodged by Neil Findlay Lab Lodged 21 Nov 2017 18 supporters Cross-party support

The motion

That the Parliament understands that there are new medicines available to treat the underlying cause of cystic fibrosis, but is concerned that access to these is being delayed until negotiations on a portfolio of new cystic fibrosis drugs is assessed and the New Medicines Review recommendations are implemented, and notes the calls both for all eligible people in Lothian and across the country to have immediate access to these medicines to prevent further decline and for established bodies such as Cystic Fibrosis Trust UK and Cystic Fibrosis Registry to be asked to capture data and assess the real value of these new medicines.

Signatures by party

18 MSPs besides the lodger · 8 from other parties
Lab 10Con 6Ind 1LD 1

Party on the day each MSP signed. Signing a motion is voluntary and not whipped. Who signs whose motions

Vote

No recorded vote on this motion. Most motions are never debated, and many that are debated are agreed without a division. Vote records are published from 2011.

Supporters

18 MSPs

Lab 10 Con 6 Ind 1 LD 1

Show all 18 supporters by party

Lab 10

Con 6

Ind 1

LD 1

Party shown is each supporter’s party when the motion was published.

In the Official Report

No contribution in the Official Report cites S5M-09067 by reference.